Abba Pharma Limited is a research driven company, continually evolving and aspires to improve products and service quality
Find Out MoreAbba Pharma Limited is a research driven company, continually evolving and aspires to improve products and service quality through the utilization of the latest technology combined with extensive research and experimentation on food ingredients and Nutraceutical products.
The technological and scientific expertise enables us to develop new and improved functional ingredients. The Research and Development’s (R&D’s) ability to explore the frontier science, to develop solutions for producing Active Ingredients in the Nutraceutical space, continues to advance our reputation as an emerging global player.
Our R&D team consists of well-experienced scientists from the best institutes in the country. The scientific talent pool is engaged in continuous interaction and participation with leading Universities and Institutions in technical programs to enable knowledge creation, and innovate in the related field of development.
Abba Pharma Limited has a fully equipped Chemical Synthesis licensed lab where the area of focus is mainly in Carbohydrate Chemistry, Functional Surfactants, Dendrimers and Natural products. The licensed lab also consists of experts in the field of Ingredients purification using novel and latest technologies.
This licensed lab is also involved in development of new products and intermediates, new machineries/equipment, as per customer requirements with target timelines.
Active Pharmaceutical Ingredients (APIs) are the active form of drugs, whose formulated dosage forms are directly used for the treatment of diseases. API research mainly focuses on the yet untapped and challenging area of carbohydrate chemistry.
The area of work is marine algal products, fungal and bacterial fermentation to produce Poly Unsaturated Fatty Acids (PUFA), Biopolymers and other related functional food ingredients.
The objective of formulation development is to develop generic drug products with emphasis on timely development of formulations for European (EU) and Rest of World (ROW) submissions. The focus of the department is to develop high quality generic products for a fast and smooth registration process and timely approval.
High quality, technology driven product development is carried out to produce a stable, clinically safe and effective formulation. A variety of dosage forms are being developed as powders (dispersible and oral-dispersible), tablets (conventional, chewable, dispersible, extended release, enteric coated etc.), capsules, ointments, creams, gels, suspensions, syrups, soft gelatin capsules and intravenous (IV) infusions.
Abba Pharma Limited assists local companies and others in developing new technologies and development of new pharma and equipment for companies looking to enter overseas markets such as in South East Asia.